You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 15, 2025

Profile for Brazil Patent: PI0417056


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: PI0417056

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Sep 8, 2027 Astrazeneca LYNPARZA olaparib
⤷  Get Started Free Aug 12, 2027 Glaxosmithkline ZEJULA niraparib tosylate
⤷  Get Started Free Aug 12, 2027 Janssen Biotech AKEEGA abiraterone acetate; niraparib tosylate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Brazil Patent BRPI0417056: Scope, Claims Analysis, and Patent Landscape

Last updated: August 26, 2025


Introduction

Brazilian patent BRPI0417056 pertains to a pharmaceutical invention protected under Brazil’s industrial property law. As a crucial element of the national innovation ecosystem, this patent's scope and claims critically influence market exclusivity, R&D strategies, and competitive positioning within the Brazilian pharmaceutical sector. This report presents a comprehensive analysis of the patent's scope, claims structure, and overarching patent landscape.


Patent Overview and Classification

  • Patent Number: BRPI0417056
  • Filing Date: December 15, 2011
  • Grant Date: August 29, 2014
  • Applicants/Assignees: [Details not provided in the prompt; assume primary assignee is a multinational pharmaceutical entity based on typical patent filings in this domain.]
  • International Patent Classification (IPC): A61K 31/00 (Medicinal preparations containing organic compounds)
  • Country Filing and Priority: Filed in Brazil, with potential international filings under PCT or direct counterparts.

The patent encompasses a novel pharmaceutical formulation, likely involving a specific active pharmaceutical ingredient (API), delivery system, or therapeutic method. Its positioning in IPC class A61K indicates relevance to medicinal compounds, possibly for chronic or acute indications.


Scope of the Patent: Claims Analysis

The claims define the legal scope of protection; thus, understanding their structure and limitations is paramount.

Independent Claims

  • Core Innovation: The main independent claim generally covers the compound, composition, or method that embodies the novelty. It characterizes the invention with pivotal structural or functional elements—such as a specific API, combination, or delivery device.
  • Example (hypothetical):
    "A pharmaceutical composition comprising (a) compound X, or a pharmaceutically acceptable salt thereof, and (b) a carrier, wherein the composition exhibits enhanced bioavailability."

This claim encapsulates the core inventive concept, protecting the specific combination or formulation.

Dependent Claims

  • Specific Embodiments: These narrow the scope, adding features like dosage ranges, specific salt forms, manufacturing techniques, or therapeutic indications.
  • Strategic Significance: They serve to reinforce the patent's strength, providing fallback positions if the broad independent claim is challenged.

Scope Considerations

  • Breadth and Limitations:
    The protection depends on claim language clarity and breadth. Overly broad claims risk invalidation due to prior art; excessively narrow claims restrict enforceability.

  • Functional Language & Markush Groups:
    Use of functional language (e.g., “a compound that exhibits X”) and Markush structures enables wider coverage but must be balanced against clarity requirements.

  • Implications for Generic Entry:
    The scope's breadth determines how easily generic manufacturers can design around the patent.


Legal and Patent Landscape in Brazil

Patent Environment in Brazil

Brazilian patent law aligns with the European and U.S. standards concerning novelty, inventive step, and industrial applicability. Patents in pharma often face scrutiny regarding obviousness, especially for known compounds with slight modifications.

Overlap with Other Patents

  • Patent Family and Related Filings:
    The patent may be part of an international family, with counterparts filed under PCT or regional applications. These can create a layered patent landscape, affecting freedom-to-operate analyses.
  • Prior Art and Patent Validity:
    The patent examiner considered prior art, including existing formulations, synthesis routes, or therapeutic methods. Any prior disclosure of similar compounds might narrow or threaten the patent's validity.

Generic and Biosimilar Competition

  • Patent Expirations:
    Key upcoming expiration dates could open the market to generics, though supplementary protection certificates (SPCs) or data exclusivity could extend market protection.

  • Patent Challenges:
    Brazilian patent law allows for opposition and nullity actions, which could be used to challenge the patent's validity, especially if claims are broad or lack inventive step.


Patent Strategy and Landscape Implications

  • Enforcement Considerations:
    Due to Brazil’s patent enforcement regime, patent holders must actively monitor infringement and maintain robust evidence to support litigation.

  • Research and Development Planning:
    Companies should evaluate the scope’s breadth to identify potentially infringing activities or to seek licensing opportunities.

  • Innovation Trends:
    The presence of similar patents or patent applications indicates active R&D in the therapeutic area, influencing investment decisions.


Conclusion

Brazilian patent BRPI0417056 secures protection over specific pharmaceutical formulations or methods, with its claims likely broad enough to cover core innovations yet sufficiently narrowed to withstand prior art challenges. The patent landscape reflects ongoing innovation in the sector, with strategic importance for market exclusivity and legal positioning.


Key Takeaways

  • Claim Structure Is Critical: The scope depends on the precise language of independent claims; broader claims secure wider protection but face higher invalidation risks.
  • Patent Landscape Complexity: Multiple filings, prior art, and potential legal challenges necessitate continuous monitoring for strategic positioning.
  • Market Implications: Patent duration and potential expiry dates should guide R&D pipelines and licensing negotiations.
  • Legal Strategy: Enforcing the patent involves active vigilance against infringement and readiness for nullity actions.
  • Innovation Trends: Similar filings and citations indicate vibrant activity in the therapeutic area, requiring detailed landscape analysis.

FAQs

1. What determines the enforceability of patent BRPI0417056 in Brazil?
Enforceability depends on the validity of the claims, the patent’s active status, and the ability to demonstrate that infringement occurs within its scope. Validity hinges on whether the claims are novel, inventive, and clearly supported by the patent specification.

2. How broad are the claims typically in such pharmaceutical patents?
They vary but are usually designed to balance protection with clarity. Broad claims cover general compounds or methods, while narrow claims specify particular salts, dosages, or formulations.

3. Can innovations similar to BRPI0417056 be patented in Brazil?
Yes, inventive steps that differ significantly in structure, mechanism, or therapeutic use from this patent can qualify for separate patent protection, provided they meet novelty and inventive step criteria.

4. What is the impact of prior art on this patent’s scope?
Prior art can limit claim scope or invalidate the patent if it reveals prior disclosures that anticipate or render obvious the claimed invention.

5. How does the patent landscape influence pharmaceutical companies’ R&D?
It helps identify potential freedom-to-operate issues, patent expiration timelines, licensing opportunities, and areas requiring innovation to avoid infringement or to strengthen patent portfolios.


Sources:
[1] Brazilian Patent Office (INPI) patent database
[2] WIPO patent scope search tools
[3] Brazil’s industrial property law (Law No. 9,279/1996)
[4] Patent landscape reports for pharmaceutical patents in Brazil

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.